Talk:Romosozumab
Appearance
This is the talk page for discussing improvements to the Romosozumab article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
![]() | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Romosozumab.
|
Interesting results from the FRAME and ARCH clinical studies
[edit]The FRAME and ARCH clinical studies reported on in Bone Loss Drug Effective, But is it Safe? - Find RS for the conclusions ? - Rod57 (talk) 16:46, 5 October 2017 (UTC)
We could say why UK NICE did not recommend
[edit]eg did NICE decide based on clinical trial results or on a cost/benefit basis ? - Rod57 (talk) 13:11, 5 January 2022 (UTC)